4//SEC Filing
SMITH IAN F 4
Accession 0001193125-26-006287
CIK 0001707502other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:05 PM ET
Size
12.0 KB
Accession
0001193125-26-006287
Insider Transaction Report
Form 4
SMITH IAN F
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-06+4,573→ 131,264 total - Award
Stock Option (Right to Buy)
2026-01-02+18,012→ 18,012 totalExercise: $5.45Exp: 2036-01-02→ Common Stock (18,012 underlying) - Award
Restricted Stock Units
2026-01-02+13,761→ 13,761 total→ Common Stock (13,761 underlying) - Exercise/Conversion
Restricted Stock Units
2026-01-06−4,573→ 0 total→ Common Stock (4,573 underlying)
Footnotes (4)
- [F1]Restricted stock units convert to common stock on a one-for-one basis.
- [F2]The Smith RSUs (as defined in footnote 3) and this option (together with the Smith RSUs, the "Smith Equity Awards") were granted on January 2, 2026 ("the Grant Date") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Fourth Amendment to Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "Smith RSUs").
- [F4]The restricted stock units were granted on January 6, 2025 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001197032
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:05 PM ET
- Size
- 12.0 KB